Anders Opdahl1, Bharath Ambale Venkatesh2, Veronica R S Fernandes2, Colin O Wu3, Khurram Nasir4, Eui-Young Choi4, Andre L C Almeida4, Boaz Rosen4, Benilton Carvalho5, Thor Edvardsen6, David A Bluemke7, João A C Lima8. 1. Cardiology Division, Johns Hopkins University, Baltimore, Maryland; Department of Cardiology, Rikshospitalet, Oslo University Hospital and University of Oslo, Oslo, Norway. 2. Department of Radiology, Mount Sinai School of Medicine, New York, New York. 3. Offices of Biostatistics Research, National Heart, Lung, and Blood Institute, Bethesda, Maryland. 4. Cardiology Division, Johns Hopkins University, Baltimore, Maryland. 5. School of Public Health, Johns Hopkins University, Baltimore, Maryland. 6. Department of Cardiology, Rikshospitalet, Oslo University Hospital and University of Oslo, Oslo, Norway. 7. National Institute for Biomedical Imaging and Bioengineering, National Institutes of Health, Bethesda, Maryland; Department of Radiology, Johns Hopkins School of Medicine, Baltimore, Maryland. 8. Cardiology Division, Johns Hopkins University, Baltimore, Maryland; Department of Radiology, Johns Hopkins School of Medicine, Baltimore, Maryland. Electronic address: jlima@jhmi.edu.
Abstract
OBJECTIVES: The objective of this study was to investigate the relationship between baseline resting heart rate and incidence of heart failure (HF) and global and regional left ventricular (LV) dysfunction. BACKGROUND: The association of resting heart rate to HF and LV function has not been well described in an asymptomatic multi-ethnic population. METHODS: Resting heart rate was measured in participants in the MESA (Multi-Ethnic Study of Atherosclerosis) trial at inclusion. Incident HF was registered (n = 176) during follow-up (median 7 years) in those who underwent cardiac magnetic resonance imaging (n = 5,000). Changes in ejection fraction (ΔEF) and peak circumferential strain (Δεcc) were measured as markers of developing global and regional LV dysfunction in 1,056 participants imaged at baseline and 5 years later. Time to HF (Cox model) and Δεcc and ΔEF (multiple linear regression models) were adjusted for demographics, traditional cardiovascular risk factors, calcium score, LV end-diastolic volume, and mass in addition to resting heart rate. RESULTS: Cox analysis demonstrated that for 1 beat/min increase in resting heart rate, there was a 4% greater adjusted relative risk for incident HF (hazard ratio: 1.04; 95% CI: 1.02 to 1.06; p < 0.001). Adjusted multiple regression models demonstrated that resting heart rate was positively associated with deteriorating εcc and decrease in EF, even when all coronary heart disease events were excluded from the model. CONCLUSIONS: Elevated resting heart rate was associated with increased risk for incident HF in asymptomatic participants in the MESA trial. Higher heart rate was related to development of regional and global LV dysfunction independent of subclinical atherosclerosis and coronary heart disease. (Multi-Ethnic Study of Atherosclerosis [MESA]; NCT00005487).
OBJECTIVES: The objective of this study was to investigate the relationship between baseline resting heart rate and incidence of heart failure (HF) and global and regional left ventricular (LV) dysfunction. BACKGROUND: The association of resting heart rate to HF and LV function has not been well described in an asymptomatic multi-ethnic population. METHODS: Resting heart rate was measured in participants in the MESA (Multi-Ethnic Study of Atherosclerosis) trial at inclusion. Incident HF was registered (n = 176) during follow-up (median 7 years) in those who underwent cardiac magnetic resonance imaging (n = 5,000). Changes in ejection fraction (ΔEF) and peak circumferential strain (Δεcc) were measured as markers of developing global and regional LV dysfunction in 1,056 participants imaged at baseline and 5 years later. Time to HF (Cox model) and Δεcc and ΔEF (multiple linear regression models) were adjusted for demographics, traditional cardiovascular risk factors, calcium score, LV end-diastolic volume, and mass in addition to resting heart rate. RESULTS: Cox analysis demonstrated that for 1 beat/min increase in resting heart rate, there was a 4% greater adjusted relative risk for incident HF (hazard ratio: 1.04; 95% CI: 1.02 to 1.06; p < 0.001). Adjusted multiple regression models demonstrated that resting heart rate was positively associated with deteriorating εcc and decrease in EF, even when all coronary heart disease events were excluded from the model. CONCLUSIONS: Elevated resting heart rate was associated with increased risk for incident HF in asymptomatic participants in the MESA trial. Higher heart rate was related to development of regional and global LV dysfunction independent of subclinical atherosclerosis and coronary heart disease. (Multi-Ethnic Study of Atherosclerosis [MESA]; NCT00005487).
Authors: J Garot; D A Bluemke; N F Osman; C E Rochitte; E R McVeigh; E A Zerhouni; J L Prince; J A Lima Journal: Circulation Date: 2000-03-07 Impact factor: 29.690
Authors: Alexander Tenenbaum; Michael Motro; Enrique Z Fisman; Jonathan Leor; Valentina Boyko; Lori Mandelzweig; Solomon Behar Journal: Am J Cardiol Date: 2002-09-01 Impact factor: 2.778
Authors: Marie Therese Cooney; Erkki Vartiainen; Tiina Laatikainen; Tinna Laakitainen; Anne Juolevi; Alexandra Dudina; Ian M Graham Journal: Am Heart J Date: 2010-04 Impact factor: 4.749
Authors: Florian Custodis; Stephan H Schirmer; Magnus Baumhäkel; Gerd Heusch; Michael Böhm; Ulrich Laufs Journal: J Am Coll Cardiol Date: 2010-12-07 Impact factor: 24.094
Authors: Michael Böhm; Karl Swedberg; Michel Komajda; Jeffrey S Borer; Ian Ford; Ariane Dubost-Brama; Guy Lerebours; Luigi Tavazzi Journal: Lancet Date: 2010-09-11 Impact factor: 79.321
Authors: Karl Swedberg; Michel Komajda; Michael Böhm; Jeffrey S Borer; Ian Ford; Ariane Dubost-Brama; Guy Lerebours; Luigi Tavazzi Journal: Lancet Date: 2010-09-11 Impact factor: 79.321
Authors: Eui-Young Choi; Boaz D Rosen; Veronica R S Fernandes; Raymond T Yan; Kihei Yoneyama; Sirisha Donekal; Anders Opdahl; Andre L C Almeida; Colin O Wu; Antoinette S Gomes; David A Bluemke; Joao A C Lima Journal: Eur Heart J Date: 2013-05-03 Impact factor: 29.983
Authors: Gert Klug; Sebastian Johannes Reinstadler; Hans-Josef Feistritzer; Christian Kremser; Johannes P Schwaiger; Martin Reindl; Johannes Mair; Silvana Müller; Agnes Mayr; Wolfgang-Michael Franz; Bernhard Metzler Journal: Eur Radiol Date: 2015-09-18 Impact factor: 5.315
Authors: Seamus P Whelton; Andreas C Mauer; Karol M Pencina; Joseph M Massaro; Ralph B D'Agostino; Caroline S Fox; Udo Hoffmann; Erin D Michos; Gina M Peloso; Line Dufresne; James C Engert; Sekar Kathiresan; Matthew Budoff; Wendy S Post; George Thanassoulis; Christopher J O'Donnell Journal: Am J Cardiol Date: 2018-02-13 Impact factor: 2.778
Authors: Chike C Nwabuo; Duke Appiah; Henrique T Moreira; Henrique D Vasconcellos; Queen N Aghaji; Bharath Ambale-Venkatesh; Jamal S Rana; Norrina B Allen; Donald M Lloyd-Jones; Pamela J Schreiner; Samuel S Gidding; João A C Lima Journal: Am J Med Date: 2020-01-27 Impact factor: 4.965
Authors: Samir Rana; Phyllis C Pugh; Erin Katz; Sara A Stringfellow; Chee Paul Lin; J Michael Wyss; Harald M Stauss; C Roger White; Sarah M Clinton; Ilan A Kerman Journal: Am J Physiol Regul Integr Comp Physiol Date: 2016-06-08 Impact factor: 3.619
Authors: Alexandra B Steverson; Anna E Pawlowski; Daniel Schneider; Prasanth Nannapaneni; Jes M Sanders; Chad J Achenbach; Sanjiv J Shah; Donald M Lloyd-Jones; Matthew J Feinstein Journal: Eur J Prev Cardiol Date: 2017-09-25 Impact factor: 7.804
Authors: Martin I Sigurdsson; Nathan H Waldron; Andrey V Bortsov; Shad B Smith; William Maixner Journal: J Cardiovasc Pharmacol Date: 2018-03 Impact factor: 3.105
Authors: Harjit Chahal; David A Bluemke; Colin O Wu; Robyn McClelland; Kiang Liu; Steven J Shea; Gregory Burke; Pelbreton Balfour; David Herrington; PeiBei Shi; Wendy Post; Jean Olson; Karol E Watson; Aaron R Folsom; Joao A C Lima Journal: Heart Date: 2014-11-07 Impact factor: 5.994
Authors: Kyndaron Reinier; Aapo L Aro; Audrey Uy-Evanado; Carmen Rusinaru; Harpriya S Chugh; Takahiro Shiota; Jonathan Jui; Sumeet S Chugh Journal: Ann Noninvasive Electrocardiol Date: 2018-08-20 Impact factor: 1.468
Authors: Andrew S Layne; Fang-Chi Hsu; Steven N Blair; Shyh-Huei Chen; Jennifer Dungan; Roger A Fielding; Nancy W Glynn; Alexandra M Hajduk; Abby C King; Todd M Manini; Anthony P Marsh; Marco Pahor; Christine A Pellegrini; Thomas W Buford Journal: Arch Phys Med Rehabil Date: 2016-08-25 Impact factor: 3.966